Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives
Shaban Ahmad, Khalid Raza
Journal of drug targeting (2024) Vol. 32, Iss. 6, pp. 635-646
Closed Access | Times Cited: 18

Showing 18 citing articles:

Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies
Shaban Ahmad, Nagmi Bano, Kushagra Khanna, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133872-133872
Closed Access | Times Cited: 10
Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins
Shaban Ahmad, Nagmi Bano, Khalid Raza
International Journal of Biological Macromolecules (2025), pp. 141703-141703
Closed Access | Times Cited: 1
The Biomedical Applications of Artificial Intelligence: An Overview of Decades of Research
Sweet Naskar, Suraj Sharma, Ketousetuo Kuotsu, et al.
Journal of drug targeting (2025), pp. 1-85
Closed Access
Lucidin from Rubia cordifolia Outperforms FDA-Approved Lapatinib as a Potential Multitargeted Candidate for Breast Cancer Signalling Proteins
Akram Ahmed Aloqbi, Hadil Alahdal, Amany I. Alqosaibi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 68-68
Open Access
Investigating the Inhibitory Effects of Paliperidone on RAGEs: Docking, DFT, MD Simulations, MMPBSA, MTT, Apoptosis, and Immunoblotting Studies
Akash Pratap Singh, Shaban Ahmad, Anamika Roy, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1060-1060
Open Access
Differential Gene Expression Analysis and Machine Learning identified Structural, TFs, Cytokine and Glycoproteins, including SOX2, TOP2A, SPP1, COL1A1, and TIMP1 as potential drivers of Lung Cancer
Syed Naseer Ahmad Shah, Rafat Parveen
Biomarkers (2025), pp. 1-16
Closed Access
Blood transcriptomics identifies FEZ1 as a potential biomarker for inflammatory bowel disease
Arman Mokaram Doust Delkhah
Computers in Biology and Medicine (2025) Vol. 187, pp. 109742-109742
Closed Access
Probing the Multitargeted Potency of FDA-approved Amifostine against MRSA and Control Comparison with Sulfamethoxazole to Establish Alternative Medications
Fawaz M. Almufarriji, Bader S. Alotaibi, Ahlam Saleh Alamri, et al.
Microbial Pathogenesis (2025), pp. 107485-107485
Closed Access
Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance
Shaban Ahmad, Navin Kumar, Hemant K. Gautam, et al.
International Journal of Biological Macromolecules (2025), pp. 142343-142343
Closed Access
Alternative use of droxidopa for treating cervical cancer: inhibiting transferase, cell cycle signalling, and transport proteins via multitarget docking, DFT, MD simulations, and binding free energy studies
Saleh Hussain A. Almasabi, Hassan H. Almasoudi, Hassan Albargy, et al.
Medical Oncology (2025) Vol. 42, Iss. 5
Closed Access
Poloxamer-based drug delivery systems: Frontiers for treatment of solid tumors
Mehdi Pourbakhsh, Masoud Jabraili, Morteza Akbari, et al.
Materials Today Bio (2025), pp. 101727-101727
Open Access
Harnessing Machine Learning Potential for Personalised Drug Design and Overcoming Drug Resistance
Mohammed Ageeli Hakami
Journal of drug targeting (2024) Vol. 32, Iss. 8, pp. 918-930
Closed Access | Times Cited: 2
Unveiling the multitargeted potential of deprodone and control comparison with linezolid against hydrolase and transferase enzymes of methicillin-resistant Staphylococcus aureus
Fawaz M. Almufarriji, Bader S. Alotaibi, Ahlam Saleh Alamri, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135459-135459
Closed Access | Times Cited: 2
Multitargeted docking approach reveals droxidopa against DNA replication and repair-related protein of cervical cancer
Ahad Amer Alsaiari, Fawaz M. Almufarriji, Ali Hazazi, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Integrating Machine Learning and Multitargeted Drug Design to Combat Antimicrobial Resistance: A Systematic Review
Nagmi Bano, Salman Arafath Mohammed, Khalid Raza
Journal of drug targeting (2024) Vol. 33, Iss. 3, pp. 384-396
Closed Access
Navigating the genomic landscape: A deep dive into clinical genetics with deep learning
Manmeet Kaur, Vandana Singh, Arshiya Khan, et al.
Elsevier eBooks (2024), pp. 185-224
Closed Access
Deep learning in predictive medicine: Current state of the art
Manoj Kumar Yadav, Manish Tripathi, Navaneet Chaturvedi, et al.
Elsevier eBooks (2024), pp. 261-291
Closed Access
Generative AI in Drug Designing: Current State-of-the-Art and Perspectives
Shaban Ahmad, Nagmi Bano, Sakshi Sharma, et al.
Studies in computational intelligence (2024), pp. 427-463
Closed Access
Page 1

Scroll to top